Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
chlorambucil | Tablet | 2 mg | |
cyclophosphamide | Injection | 1 g | |
cyclophosphamide | Injection | 200 mg/10mL | |
cyclophosphamide | Tablet | 50 mg | |
ifosfamide | Powder for injection | 1 g in vial | |
ifosfamide | Powder for injection | 2 g in vial | |
lomustine | Capsule | 40mg | |
melphalan | Tablet | 2 mg | |
mesna | Injection | 400mg/ 4 mL (vial) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
bupivacaine | Injection | 0.5% (hydrochloride) in 10 mL | |
bupivacaine | Injection for spinal anaesthesia | 5 mg/mL in 4 mL | |
lidocaine | Gel | 2% | |
lidocaine | Injection | 2% (hydrochloride) in vial | |
lidocaine + epinephrine (adrenaline) | Injection | 2% X 50ML | |
lidocaine + prilocaine | Cream | 2.5%/2.5% |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
fulvestrant | Injection | 50MG/ML X 5ML | |
tamoxifen | Tablet | 20 mg (as citrate) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
azithromycin | Powder for oral suspension | 200 mg | |
capecitabine | Tablet | 500 mg | |
fluorouracil | Injection | 500mg/10ml | |
mercaptopurine | Tablet | 50 mg | |
methotrexate | Injection | 1 gm | |
methotrexate | Injection | L.P.F 25MG/ML X 2ML | |
methotrexate | injection for intravenous administration | 50MG/2ML | |
methotrexate | Tablet | 2.5 mg | |
thioguanine | Solid oral dosage form | 40 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
aprepitant | Capsule | 125 mg/2 x 80 mg | |
granisetron | Injection | 3 mg in ampoule | |
granisetron | Tablet | 1 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
albendazole | Suspension | 100 mg/5 ml | c2 |
albendazole | Tablet (chewable) | 400 mg | |
metronidazole | Injection | 500 mg in 100-mL vial | |
metronidazole | Suspension | 250 mg/5 mL | |
metronidazole | Tablet | 400 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
fluconazole | Capsule | 200 mg | |
fluconazole | Capsule | 50 mg | |
fluconazole | Capsule | 50-150 mg | |
fluconazole | Injection | 200 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
dapsone | Tablet | 100 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
chloroquine | Tablet | 250mg (150mg base) as phosphate | |
hydroxychloroquine | Solid oral dosage form | 200 mg (as sulfate) | |
mefloquine | Tablet | 250 mg | |
primaquine | Tablet | 15 mg (as diphosphate) | |
proguanil | Tablet | 100 mg (as hydrochloride) | |
pyrimethamine | Tablet | 25 mg | |
quinine | Injection | 300 mg quinine hydrochloride/mL in 2-mL ampoule | |
quinine | Injection | 600mg (dichlorohydrate) | |
quinine | Tablet | 300 mg (quinine bisulfate) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
ethambutol | Tablet | 400mg (chlorohydrate) | |
isoniazid | Tablet | 100mg | |
isoniazid | Tablet | 300mg | |
pyrazinamide | Tablet | 500 mg | |
rifampicin | Capsule | 150 mg | |
rifampicin | Capsule | 300 mg | |
rifampicin | Suspension | 100mg/5ml |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
aciclovir | Cream | 5% | |
aciclovir | Injection | 250 mg/10 ml | |
aciclovir | Suspension | 200 mg/125 ml | |
aciclovir | Tablet | 200 mg | |
azidothymidine | Syrup | 10 mg/ml x 240 ml | |
indinavir (IDV) | Solid oral dosage form | 400 mg (as sulfate) | |
oseltamivir | Powder | 75 mg | |
oseltamivir | Tablet | 75 mg | |
valacyclovir | Tablet | 500mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
ciprofloxacin | Solution for IV infusion | 200 mg in 100 mL vial | |
ciprofloxacin | Tablet | 500 mg | |
levofloxacin | Injection | 500 mg/100 mL vial | |
levofloxacin | Tablet | 500 mg | |
moxifloxacin | Injection | 400 mg/250 ml | |
moxifloxacin | Tablet | 400 mg | |
norfloxacin | Tablet | 400 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
co-trimoxazole | Injection | 96 mg/ml x 5 ml IV | |
co-trimoxazole | Suspension | 240 mg/5 ml | |
co-trimoxazole | Tablet | 480 mg | |
sulfadiazine | Tablet | 500 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
nitrofurantoin | Tablet | 100 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
abacavir | Suspension | 20 mg/ml x 240 ml | |
abacavir (ABC) | Tablet | 300 mg | |
abacavir + lamivudine + zidovudine | Tablet | 300 mg + 150 mg + 300 mg | |
atazanavir | Solid oral dosage form | 150 mg (as sulfate) | |
azidothymidine | Injection | 10 mg/ml x 20 ml | |
darunavir | Tablet | 300 mg | |
darunavir | Tablet | 600 mg | |
efavirenz (EFV or EFZ) | Capsule | 200 mg | |
efavirenz (EFV or EFZ) | Capsule | 600 mg | |
efavirenz + emtricitabine + tenofovir | Tablet | 600 mg + 200 mg + 300 mg | |
emtricitabine + tenofovir | Tablet | 200 mg + 300 mg | |
etravirine | Tablet | 100 mg | |
ganciclovir | Injection | 500 mg (sodium) | |
lamivudine (3TC) | Capsule | 150 mg | |
lamivudine (3TC) | Suspension | 100 mg/ml x 240 ml | |
lamivudine + nevirapine + zidovudine | Tablet | 150 mg + 200 mg + 300 mg | |
lamivudine + zidovudine | Capsule | 150 mg/ 300 mg | |
lopinavir + ritonavir (LPV/r) | Oral liquid | 80 + 20 mg/ml | |
lopinavir + ritonavir (LPV/r) | Tablet (heat stable) | 200 mg + 50 mg | |
nevirapine (NVP) | Suspension | 10mg/ml | |
nevirapine (NVP) | Suspension | 50 mg/5 ml x 100 ml | |
nevirapine (NVP) | Tablet | 200 mg | |
raltegavir | Tablet | 400 mg | |
ritonavir | Oral liquid | 80 mg/ml | |
ritonavir | Tablet (heat stable) | 100 mg | |
saquinavir (SQV) | Solid oral dosage form | 500 mg (as mesilate) | |
tenofovir + lamivudine | Capsule | 300 mg + 300 mg | |
tenofovir disoproxil fumarate | Tablet | 300 mg | |
valgancyclovir | Tablet | 450mg | |
zidovudine (ZDV or AZT) | Capsule | 300 mg | |
zidovudine (ZDV or AZT) | Suspension | 10 mg/ml | c1 |
zidovudine (ZDV or AZT) | Tablet | 100 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
amikacin | Injection | 500 mg (sulfate)/2 mL | |
gentamicin | Injection | 80 mg (sulfate)/2 mL | |
streptomycin | Injection | 1g (sulfate) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
amphotericin B | Powder for injection | 50 mg in vial | |
nystatin | Oral suspension | 100000U/ML x 60 ML |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
ertapenem | Powder for injection | 1g | |
imipenem + cilastatin | Injection | 500mg + 500mg | |
meropenem | Injection | 500 mg | |
meropenem | Powder for injection | 1 g |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
cefazolin | Injection | 500 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
cefaclor | Capsule | 250 mg | |
cefaclor | Suspension | 125 mg/5 ml x 60 ml | |
cefaclor | Suspension | 250 mg/5 ml x 60 ml | |
cefuroxime | Injection | 1.5 g | |
cefuroxime | Tablet | 250 mg | |
cefuroxime | Tablet | 500 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
cefotaxime | Powder for injection | 1 g (as sodium salt) | |
ceftazidime | Injection | 1 g | |
ceftriaxone | Powder for injection | 1 g (as sodium salt) in vial | |
ceftriaxone | Powder for injection | 250 mg (as sodium salt) in vial |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
cefepime | Injection | 1 g in vial |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
azithromycin | Suspension | 200 mg/5 ml x 15 ml | |
azithromycin | Tablet | 500 mg | |
clarithromycin | Suspension | 125 mg/5 ml | c2 |
clarithromycin | Tablet | 250mg | |
erythromycin | Suspension | 200 mg/5 ml x 100 ml | |
erythromycin | Tablet (enteric-coated) | 250 mg (stearate) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
clindamycin | Capsule | 150 mg (as hydrochloride) | |
linezolid | Injection | 600MG/300ML | |
linezolid | Tablet | 600 mg | |
vancomycin | Injection | 500 mg (chlorohydrate) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
amoxicillin | Capsule | 250 mg | |
amoxicillin | Powder for oral liquid | 125 mg (as trihydrate)/5 mL | |
amoxicillin + clavulanic acid | Injection | 1 gm/200 mg | |
amoxicillin + clavulanic acid | Injection | 500 mg/100 mg | |
amoxicillin + clavulanic acid | Suspension | 228 mg/5 ml x 70 ml | |
amoxicillin + clavulanic acid | Tablet | 500 mg (as trihydrate) + 125 mg (as potassium salt) | |
amoxicillin + clavulanic acid | Tablet | 875mg + 125mg | |
ampicillin | Powder for injection | 500 mg | |
benzathine benzylpenicillin | Injection | 1 200 000 IU | |
benzathine benzylpenicillin | Injection | 2 400 000 IU | |
benzylpenicillin | Powder for injection | 1 million IU | |
cloxacillin | Injection | 500 mg | |
phenoxymethylpenicillin | Syrup | 125 mg/5 ml x 100 ml | |
phenoxymethylpenicillin | Tablet | 250 mg | |
piperacillin sodium + tazobactum sodium | Injection | 4.5 gm | |
tigecycline | Injection | 50 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
doxycycline | Capsule | 100 mg (as hydrochloride or hyclate) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
dabigatran | Capsule | 110 mg | |
dabigatran | Capsule | 150 mg | |
rivaroxaban | Tablet | 10 mg | |
rivaroxaban | Tablet | 15 mg | |
rivaroxaban | Tablet | 20 mg | |
warfarin | Tablet | 1 mg (sodium salt) | |
warfarin | Tablet | 5 mg (sodium salt) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
terra fullonica | Powder | N/A |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
acetylcysteine | Injection | 200 mg/ml in 10-ml ampoule | |
pralidoxime | Injection | 1g (chlorohydrate) | |
prazosin | Tablet | 1mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
chlorphenamine | Injection | 10 mg (hydrogen maleate) in 1-ml ampoule | |
chlorphenamine | Oral liquid | 2 mg/5 ml (hydrogen maleate) | |
chlorphenamine | Tablet | 4 mg (hydrogen maleate) | |
diphenhydramine | Oral liquid | 12.5 mg/5 mL |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
loratadine | Oral liquid | 5 mg/mL | |
loratadine | Tablet | 10 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
cytarabine | Injection | 1 GM | |
cytarabine | Powder for injection | 100 mg in vial | |
dacarbazine | Injection | 200 mg | |
erlotinib | Tablet | 150 mg | |
gefitinib | Tablet | 250 mg | |
gemcitabine | Injection | 1g | |
gemcitabine | Injection | 200mg | |
leuprorelin (leuprolide acetate) | Injection | 11.25 MG | |
pazopanib | Tablet | 200 MG | |
pazopanib | Tablet | 400 MG | |
pemetrexed | Injection | 500 MG | |
retinoic acid | Capsule | 10 mg | |
rituximab | Injection | 500 mg/50 mL | |
sorafenib | Tablet | 200 MG | |
temozolomide | Capsule | 100 MG | |
temozolomide | Capsule | 400 MG | |
vinorelbine | Injection | 50 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
acetylsalicylic acid | Tablet | 81mg | |
clopidogrel | Tablet | 75 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
bleomycin | Injection | 15 IU | |
dactinomycin | Powder for injection | 500 mcg in vial | |
daunorubicin | Injection | 20mg (chlorohydrate) | |
doxorubicin | Powder for injection | 10 mg (hydrochloride) in vial | |
doxorubicin | Powder for injection | 50 mg (hydrochloride) in vial | |
epirubicin | Injection | 10 mg/5 ml | |
epirubicin | Injection | 50 mg/25 ml | |
mitomycin | Injection | 5 mg | |
mitoxantrone | Injection | 20 mg/ 10 ml |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
anastrozole | Tablet | 1mg | |
exemestane | Tablet | 25 mg | |
letrozol | Tablet | 2.5 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
neostigmine | Injection | 2.5 mg (metilsulfate) in 1-ml ampoule | |
pyridostigmine | Tablet | 60 mg (bromide) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
atropine | Injection | 0.6 mg/ml |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
sodium bicarbonate | Injection | 8.4% |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
amino acids + carbohidrate | Injection | 10% - 500 ml | |
dextrose | Injection | 50% - 500 ml | |
dextrose | injection for intravenous administration | 5% saline 0.45% - 1000 ml | |
dextrose | injection for intravenous administration | 5% sodium chloride 0.2% - 1000 ml | |
dextrose | injection for intravenous administration | 5% sodium chloride 0.9% - 1000 ml | |
dextrose | Solution for injection | 10 % - 1000 mL. | |
dextrose | Solution for injection | 5% - 1000 mL. | |
dextrose | Solution for injection | 5% - 500 mL. | |
dextrose | Solution for injection | 50% - 50 mL | |
fractionated soya | oil | 10% | |
fractionated soya | oil | 20% | |
sorbitol for urologic irrigation | Solution | 3.3% - 4 l |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
acetazolamide | Tablet | 250 mg | |
bendrofluazide | Tablet | 5 mg | |
frusemide | Injection | 10 mg/ml x 2 ml | |
furosemide | Tablet | 40 mg | |
mannitol | Intravenous administration | 20% | |
spironolactone | Tablet | 25 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
calcium carbonate | Tablet | 750 mg | |
calcium chloride | Injection | 18 g NDL 10% x 10 ml | |
calcium gluconate | Injection | 10% | |
haemodialysis | Solution | 5L | |
haemodialysis acid concentrated | Solution | N/A | |
haemodialysis bicarbonate concentrate | Powder | N/A | |
oral rehydration salts | Powder | 28 gm | |
peritoneal dialysis solution | Solution | 2.5% x 2 L | |
plasma protein fraction | Injection | 25% x 50 ml | |
plasma protein fraction | Liquid | 5% x 250 ml | |
polygeline | Solution | 500 ml | |
potassium chloride | Injection | 1.5 mg/ml x 10 ml | |
potassium chloride | Tablet | 600 mg | |
sevelamer carbonate | Tablet | 800 mg | |
sodium chloride | Injection | 23.4% 30 ml | |
sodium chloride | Intravenous administration | 0.9% 1 litre | |
sodium chloride | Solution | 0.9% 250 ml | |
sodium chloride | Solution | 0.9% 500 ml | |
sodium chloride | Solution | 3% x 500 ml | |
sodium lactate co hartman full | Intravenous administration | 1000 ml | |
sodium polystrene sulphonate | Powder | 500 gm | |
water for injection | Injection | 100 ml multi dose | |
water for injection | N/A | 10-ml ampoules |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
alendronic acid | Tablet | 70mg (as alendronate sodium) | |
ibandronic acid | Tablet | 150 mg | |
strontium ranelate | Powder | N/A | |
zolendronate | Injection | 4mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
ferric ammonium citrate/ folic acid | Liquid | 125 ml | |
ferrous sulfate | Tablet | 200 mg | |
folic acid | Tablet | 5 mg | |
iron sucrose | Injection | 100 mg/ 5 ml |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
heparin sodium | Injection | 1000 U/ml x 5 ml | |
heparin sodium | Injection | 5000 IU/mL in 5-mL vial |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
deferasirox | Tablet | 125 mg | |
deferasirox | Tablet | 250 mg | |
deferasirox | Tablet | 500 mg | |
deferiprone | Tablet | 500 mg | |
desferrioxamine mesilate | Injection | 0.5 gm |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
protamine sulfate | Injection | 10 mg/mL in 5-mL ampoule |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
tenecteplase | Injection | 50 mg/ 10000 U |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
epoetin beta | Injection | 4000 U/ 0.3 ml | |
epoetin beta | Injection | 50000UI/10 ml | |
epoetin beta/ methoxy polyethylene glycol | Injection | 100 mcg/ 0.3 ml | |
epoetin beta/ methoxy polyethylene glycol | Injection | 50 mcg/ 0.3 ml | |
erythropoietin alpha | Injection | 40 000 UI/ 10 ml | |
erythropoietin alpha | Injection | 4000 U/ ml | |
erythropoietin beta | Injection | 30 000 UI/0.6 ml | |
interferon alpha 2B | Injection | 5 000 000 IU | |
interferon alpha-2A pegylated | Injection | 4.5 MU | |
interferon beta | Injection | 0.25 mg | |
pegylated interferon | Injection | N/A | |
ribavirin | Tablet | 200 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
factor IX | Solution | N/A | |
factor VIII | N/A | N/A | |
factor VIII concentrate | Injection | N/A | |
tranexamic acid | Injection | 100 mg/ml in 10-ml ampoule |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
enoxaparin | Injection | 40 mg/ 0.4 ml | |
enoxaparin | Injection | 60 mg/ 0.6 ml |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
brimonidine / timolol | dro | 2% / 0.5% | |
dorzolamide + timolol | dro | 2% / 0.5% |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
diclofenac | Injection | 75 mg/3 mL | |
diclofenac | Tablet | 100 mg | |
ibuprofen | Suspension | 100 mg/5 mL | |
ibuprofen | Tablet | 400 mg | |
mefenamic acid EC | Tablet | 500 mg | |
naproxen | Tablet | 250 mg (sodium) | |
naproxen | Tablet | 500 mg (sodium) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
acetylsalicylic acid | Tablet | 500 mg | |
paracetamol | Injection | 10 mg/ ml | |
paracetamol | Suppository | 125mg (infantile) | |
paracetamol | Suppository | 60 mg | |
paracetamol | Tablet | 500 mg | |
paracetamol + acetaminophen | Syrup | 120 mg/ 5 ml |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
carbamazepine | Suspension | 2% x 100 ml | |
carbamazepine | Tablet | 200 mg | |
divalproex sodium | Tablet | 250 mg | |
divalproex sodium | Tablet | 500 mg | |
lamotrigine | Tablet | 100 mg | |
lamotrigine | Tablet | 25 mg | |
magnesium sulfate | Injection | 50% x 2 ml | |
magnesium sulfate | Injection | 50% x 20 ml | |
phenytoin | Capsule | 100 mg | |
phenytoin | Injection | 250 mg (sodium)/5 mL | |
phenytoin | Suspension | 125 mg/ 5 ml x 240 ml | |
pregabalin | Capsule | 300 mg | |
topiramate | Tablet | 100 mg | |
topiramate | Tablet | 25 mg | |
valproic acid (sodium valproate) | Suspension | 200 mg/5 ml x 300 ml | |
valproic acid (sodium valproate) | Tablet (enteric-coated) | 200 mg (sodium valproate) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
amitriptyline | Tablet | 25 mg | |
imipramine chlorohydrate | Tablet | 25mg |